Cronos Total Stockholder Equity from 2010 to 2024

Stocks . Canada . 
Stock . Cronos Group
CRON Stock  CAD 2.93  0.05  1.68%   
Cronos Total Stockholder Equity yearly trend continues to be very stable with very little volatility. Total Stockholder Equity is likely to drop to about 730.8 M. Total Stockholder Equity is the total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders. View All Fundamentals
 
Total Stockholder Equity  
First Reported
2014-06-30
Previous Quarter
1.1 B
Current Value
1.1 B
Quarterly Volatility
680.8 M
 
Yuan Drop
 
Covid
Check Cronos financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cronos' main balance sheet or income statement drivers, such as Interest Expense of 27.2 M, Selling General Administrative of 43.8 M or Total Revenue of 91.6 M, as well as many indicators such as Price To Sales Ratio of 8.66, Dividend Yield of 0.0 or PTB Ratio of 0.69. Cronos financial statements analysis is a perfect complement when working with Cronos Valuation or Volatility modules.
  
This module can also supplement various Cronos Technical models . Check out the analysis of Cronos Correlation against competitors.
When determining whether Cronos Group offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cronos' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cronos Group Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cronos Group Stock:
How To Invest In Cronos
Details
Is Cronos Stock a good investment?
Details
What is Cronos' Net Worth?
Details
Largest Pharmaceuticals Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out the analysis of Cronos Correlation against competitors.
You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Altman
Z Score
Details
Intrinsic
Valuation
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between Cronos' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cronos is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cronos' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY